Faeth Therapeutics, Inc
Price
FilingsNewest: 8-K, Director or officer changeSep 17 →Insiders6 insiders bought $1.8M in 35 open-market buys. 6 insiders sold $2.3M, 0 of 45 sales on a 10b5-1 plan.→HoldersMontanova Capital 7.8%Avoro Capital 5.6%Baker Bros 5.0%→Financing →PeersClosest companies: ARVN, CLRB, KPTI→
From the filings
Figures
- Net income
- −$195.5Mlast 12 months
- Operating cash flow
- −$24.1Mlast 12 months
- Cash and equivalents
- $26.9Mat the last balance sheet
- Shares outstanding
- 25.8M shareson issue